Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
08/2008
08/12/2008US7410984 novel pyridone derivatives capable of inhibiting alpha 4 integrin mediated cell adhesion; to treat chronic inflammatory diseases; 3-(4-{2-Oxo-3-[4-(3-o-tolyl-ureido)phenyl]-2H-pyridin-1-ylmethyl}phenyl)propionic acid; hydrolysis
08/12/2008US7410958 3 beta -1-(N',N'-dimethylaminopyridinium)-N-acetyloxy-19 beta ,28-epoxy-18 alpha -oleanan chloride; Plant fungicides and bactericides; antibiotic resistant staphylococcus and enterococcus; turf grasses; improved chemical resistance and stability
08/12/2008US7410955 Therapeutic use of agonist ligands specific to G2A receptor
08/12/2008US7410946 Method for treating damage in intact skin comprising administering a composition comprising basic milk growth factors in amounts higher than those in milk
08/12/2008US7410652 Controlled release and taste masking oral pharmaceutical composition
08/12/2008US7410651 Controlled release and taste masking oral pharmaceutical composition
08/12/2008US7410647 Vaccines
08/12/2008US7410646 Immunologically active polypeptides with altered toxicity useful for the preparation of an antipertussis vaccine
08/12/2008US7410645 Moraxella (Branhamella) catarrhalis antigens
08/12/2008US7410642 Assays and therapies for latent viral infection
08/12/2008CA2398111C 4-pyridyl-and 2,4-pyrimidinyl-substituted pyrrole derivatives and their use in pharmacy
08/12/2008CA2330235C Antigenic complex comprising immunostimulatory peptide, cd4, and chemokine receptor domain for hiv treatment and immune disorders
08/12/2008CA2184828C Composition for inactivating irritants in fluids
08/08/2008CA2619157A1 Anti-human papillomas virus composition
08/07/2008WO2008095093A2 Method of increasing cellular function and health of glutathione deficient animals
08/07/2008WO2008094065A1 METHOD AND A THERAPEUTIC AGENT WHICH IS USED FOR TREATING VIRAL HEPATITIS AND BASED ON Enterococcus Faecium M (VKPM B-3490) AND Enterococcus faecium M-3185 (VKPM B- 3491) STRAINS
08/07/2008WO2008093700A1 Trehalose compound, process for production of the compound, and immuno-stimulative agent comprising the compound
08/07/2008WO2008093614A1 Novel hepatitis c virus inhibitor
08/07/2008WO2008093464A1 Animal having modification in mgat2 gene
08/07/2008WO2008093280A2 Anti-idiotype monoclonal antibodies as mimotopes of the hiv gp120 antigen
08/07/2008WO2008092928A2 NOVEL ß-LACTAM ANTIBIOTICS, METHOD FOR THE PRODUCTION THEREOF, AND USE THEREOF
08/07/2008WO2008092826A2 Cistus extracts
08/07/2008WO2008092690A1 Aminoglycoside antibiotics targeting bacterial 16s ribosomal rna
08/07/2008WO2008092675A1 Phenol-derivatives for use as feed additive
08/07/2008WO2008092576A1 Enrofloxacin-hexahydrate
08/07/2008WO2008092466A1 Antiviral combination for treatment of hcv & hbv
08/07/2008WO2008092396A1 Microcapsule formulation of kitasamycin, process for preparation thereof and use thereof
08/07/2008WO2008092199A1 Thiopyrimidine-based compounds and uses thereof
08/07/2008WO2008076806A9 Compositions and methods to potentiate colistin activity
08/07/2008WO2008076261A3 Water-soluble phenicol prodrugs in a lipophilic vehicle system
08/07/2008WO2008076225A3 Non-nucleoside reverse transcriptase inhibitors
08/07/2008WO2008054639A3 Use of a catechin or polyphenol to treat ocular diseases and infection
08/07/2008WO2008053219B1 Composition for the treatment of gastrointestinal diseases
08/07/2008WO2008042240A9 Enantiomerically pure phosphoindoles as hiv inhibitors
08/07/2008WO2008036642A3 N-hydroxyamidinoheterocycles as modulators of indoleamine 2,3-dioxygenase
08/07/2008WO2008026915A3 A pharmaceutical composition for the treatment of a fungal skin disorder and a method for the preparation thereof
08/07/2008WO2008009655B1 Medical use of n-phenylpropenoyl-amino acid derivatives and related compounds
08/07/2008WO2007079052A3 Novel immunologically active peptide fragments of a proline-rich polypeptide isolated from colostral mammalian fluids for treatment of viral and non-viral diseases or diseased conditions
08/07/2008WO2007068116A8 Method for correcting a lipid imbalance in a subject
08/07/2008WO2006022409A8 Hazardous substance scavenger and application apparatus and application method therefor
08/07/2008US20080188640 Immunodeficiency recombinant poxvirus
08/07/2008US20080188568 Stabilizing positively charged active ingredient inside beads; penetration; shelf life
08/07/2008US20080188566 Hydroxamic acid derivatives of 3-Phenyl propionic acids useful as therapeutic agents for treating anthrax poisoning
08/07/2008US20080188565 Hydroxamic acid derivatives of phenoxy-acetic acids and analogs useful as therapeutic agents for treating anthrax poisoning
08/07/2008US20080188544 Lyophilized formulations of salinosporamide a
08/07/2008US20080188536 2-thiophenecarboxylic acid-5-nitro-2-(2-thienylcarbonyl)hydrazide; antibacterial agent; inhibition of formation of biofilms in personal hygiene articles, toileteries, cosmetics and in industrial setting; bacterial damage or disease; Pseudomonas aeruginosa or Burkholderia cepacia
08/07/2008US20080188535 2-thiophenecarboxylic acid-5-nitro-2-(2-thienylcarbonyl)hydrazide; antibacterial agent; inhibition of formation of biofilms in personal hygiene articles, toileteries, cosmetics and in industrial setting; bacterial damage or disease; Pseudomonas aeruginosa or Burkholderia cepacia
08/07/2008US20080188528 Modulators of C3a receptor and methods of use thereof
08/07/2008US20080188516 Imiadazo[4,5-c] pyridine compound and method of antiviral treatment
08/07/2008US20080188515 metalloproteinases inhibitor, particular Peptide Deformylase (Pdf) inhibitor; antibiotic; e.g. 2-(6-fluoro-imidazo[1,2-a]pyridin-3-ylamino)-N-hydroxy-acetamide
08/07/2008US20080188513 Good aqueous solubility and good physical and chemical stability in solid form; chemical intermediates
08/07/2008US20080188501 retrovirus inhibor; anticarcinogenic, antidiabetic agent, immunosuppressant, autoimmune diseases; 2-{6-[3(R)-Amino-piperidin-1-yl]-3-methyl-2,4-dioxo-3,4-dihydro-2H-pyrimidin-1-ylmethyl}-4-fluoro-benzonitrile; type 2 diabetes mellitus, impaired glucose tolerance, obesity, multiple sclerosis
08/07/2008US20080188499 catecholpyrazine analogs, e.g. 2-[2-(5-nitro-2-furyl)vinyl]-4-[2-(3,4-dihydroxyphenyl)ethylamino]quinazoline; inhibitors of bacterial lipid A biosynthesis; antibiotic and bactericide; sterilization agent and antiseptic
08/07/2008US20080188491 Modulation of pathogenicity
08/07/2008US20080188481 e.g. 1-[4-(1-Phenyl-1-(pyrazinyl)-methylene)-piperidin-1-yl]-2-(4-methoxy-7-pyrazinyl-6-azaindol-3-yl)-ethane-1,2-dione; viricides for prophylaxis of lympadenopathy associated virus; synergystic mixtures with immunomodulators
08/07/2008US20080188473 Indoles Useful in the Treatment of Inflammation
08/07/2008US20080188470 Oxazolidinone Derivatives as Antimicrobials
08/07/2008US20080188469 Vaccination
08/07/2008US20080188466 Antiviral agent especially to treat hepatitis C virus infections; 5-Hydroxy-4-(7-methoxy-1,1-dioxo-1,2-dihydro-1 lambda 6-benzo[1,2,4]thiadiazin-3-yl)-2-(3-methyl-butyl)-6-thiophen-2-yl-2H-py-ridazin-3-one; side effects reduction
08/07/2008US20080188458 Enzyme inhibitors; interferons; interleukins; cyclosporins; Cycloprop[d]indolo[2,1-a][2]benzazepine/indolo[2,1-a][2]benzazepine derivatives; N'-(5-((sec-Butylsulfonyl)carbamoyl)-8-cyclohexyl-11-methoxy-1,12b-dihydrocyclopropa[d]indolo[2,1-a][2]benzazepin-1a(2H)-yl)-N,N-dimethylethanediamide
08/07/2008US20080188440 Beta-L-2'-Deoxy-Nucleosides for the Treatment of Hepatitis B
08/07/2008US20080188428 Bioinformatically detectable group of novel hiv regulatory genes and uses thereof
08/07/2008US20080188417 Beta-like glycoprotein hormone polypeptide and heterodimer
08/07/2008US20080188410 Apoptosis-inducing polypeptides
08/07/2008US20080188399 Drug-Polymer Conjugates Coupled to a Peptidic Carrier
08/07/2008US20080187575 Pyrimidine Derivatives
08/07/2008US20080187554 Solubilizing t-helper epitopes in buffer comprising succinic acid and manitol for use in immunoglobulin to prevent and treat human immunodeficiency viral infection; vaccines; immunotherapy
08/07/2008US20080187552 Novel vaccine composition and use of surfactants as adjuvants of immunity
08/07/2008US20080187550 Using bacterial dnaJ chaperone protein sequences as agent to enhance immune respone; for use in treatment and prevention of arthritic inflammation
08/07/2008US20080187545 Cytomegalovirus surface protein complex for use in vaccines and as a drug target
08/07/2008US20080187541 Helicobacter pylori adhesin binding group antigen
08/07/2008US20080187538 Posh nucleic acids, polypeptides and related methods
08/07/2008US20080187537 Using immunodeficient animals to generate cancer cell infiltrating lymphocytes; immunotherapy; tissue targeted therapy
08/07/2008US20080187516 Acyclic oximyl hepatitis c protease inhibitors
08/07/2008DE102007006122A1 Cistusextrakte Cistusextrakte
08/07/2008DE102007004732A1 Enrofloxacin-Hexahydrat Enrofloxacin hexahydrate
08/07/2008DE10132669B4 Pharmakologische Zubereitung aus einem nanopartikulären mesomorphen Polyelektrolyt-Lipid-Komplex und mindestens einem Wirkstoff Pharmacological preparation of a nanoparticulate mesomorphic polyelectrolyte-lipid complex and at least one active ingredient
08/07/2008CA2702647A1 Thiopyrimidine-based compounds and uses thereof
08/07/2008CA2677044A1 Novel .beta.-lactam antibiotics, methods for their production, and their use
08/07/2008CA2676822A1 2-5a analogs and their methods of use
08/07/2008CA2676698A1 Enrofloxacin-hexahydrate
08/07/2008CA2676551A1 Compositions and methods of use of phorbol esters
08/07/2008CA2659275A1 Chimeric influenza virus-like particles
08/06/2008EP1953171A1 Aminoglycoside antibiotics targeting bacterial 16S ribosomal RNA
08/06/2008EP1953147A1 Heterocyclic compound and medicinal application thereof
08/06/2008EP1953138A2 Fenicol compounds and methods of synthesizing 2-trifluoracetamido-3-substituted propiophenone compounds
08/06/2008EP1951889A2 Vancomycin formulations having reduced amount of histamine
08/06/2008EP1951872A2 Splice switching oligomers for tnf superfamily receptors and their use in treatment of disease
08/06/2008EP1951865A1 Stabilizing formulations for recombinant viruses
08/06/2008EP1951745A2 Casein-derived antimicrobial peptides and lactobacillus strains that produce them
08/06/2008EP1951743A1 Hepatitis c virus inhibitors
08/06/2008EP1951737A2 Rnai inhibition of influenza virus replication
08/06/2008EP1951708A2 Piperazine derivatives useful as ccr5 antagonists
08/06/2008EP1951705A1 Novel antifungal triazole derivatives
08/06/2008EP1951671A2 New pleuromutilin derivative and its use
08/06/2008EP1951374A1 Treatment of sub-gingival pocket infections
08/06/2008EP1951311A1 Lipopeptide compositions
08/06/2008EP1951306A2 Reduction and prevention of cell-associated hiv transepithelial migration, microbides and other formulations and methods
08/06/2008EP1951285A2 Interferon in influenza
08/06/2008EP1951272A1 Use of lactobacillus for treatment of virus infections
1 ... 703 704 705 706 707 708 709 710 711 712 713 714 715 716 717 718 719 720 721 722 723 ... 1798